Showing results (1101-1110 of 1,878) with videos related to
Sort By:
Pageof 188
Immunotherapy|November 19, 2019
Cost-effectiveness of pembrolizumab versus chemotherapy as first-line treatment in PD-L1-positive advanced non-small-cell lung cancer in the USAMin Huang, Gilberto de Lima Lopes, Ralph P Insinga, et al.Immunotherapy|November 6, 2019
Reslizumab and mepolizumab for moderate-to-severe poorly controlled asthma: an indirect comparison meta-analysisKevin Yan, Chakrapani Balijepalli, Rohini Sharma, et al.Immunotherapy|July 8, 2021
TYK2 as a therapeutic target in the treatment of autoimmune and inflammatory diseasesMaciej Gonciarz, Katarzyna Pawlak-Buś, Piotr Leszczyński, et al.Immunotherapy|July 12, 2021
Enteric plexus neuropathy associated with PD-L1 blockade in a patient with small-cell lung cancerIoannis P Trontzas, Vasiliki E Rapti, Nikolaos K Syrigos, et al.Immunotherapy|January 5, 2021
Adenosine triphosphate, polymyxin B and B16 cell-derived immunization induce anticancer responseCarlos Barrera-Avalos, Javier Mena, Ximena López, et al.Immunotherapy|July 30, 2021
Patient needs and benefits of sublingual immunotherapy for grass pollen-induced allergic rhinitis: an observational studyToni Maria Klein, Meike Hadler, Matthias Augustin, et al.Immunotherapy|April 6, 2013
Complement-dependent cytotoxicity of an antibody to melanin in radioimmunotherapy of metastatic melanomaThomas Jandl, Ekaterina Revskaya, Zewei Jiang, et al.Immunotherapy|December 18, 2012
An IL-17 peptide-based and virus-like particle vaccine enhances the bioactivity of IL-17 in vitro and in vivoQingdong Guan, Carolyn R Weiss, Gefei Qing, et al.Immunotherapy|December 18, 2012
Improved IgG3 levels and reduced infection rate in a woman with CVID switched from intravenous to subcutaneous immunoglobulin therapyRalph S ShapiroImmunotherapy|December 18, 2012
Bone marrow transplantation in epidermolysis bullosaAlya Abdul-Wahab, Gabriela Petrof, John A McGrathPageof 188